ArticleImmunity, inflammation and disease2024

Post-COVID immunity in patients with solid tumor or hematological malignancies treated with SARS-CoV-2 monoclonal antibodies.

Gilberto Sabino-Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.